Antimicrobial Defense by Phagocyte Extracellular Traps
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Eosinophil-Derived Neurotoxin (EDN/Rnase 2) and the Mouse Eosinophil-Associated Rnases (Mears): Expanding Roles in Promoting Host Defense
Int. J. Mol. Sci. 2015, 16, 15442-15455; doi:10.3390/ijms160715442 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense Helene F. Rosenberg Inflammation Immunobiology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; E-Mail: [email protected]; Tel.: +1-301-402-1545; Fax: +1-301-480-8384 Academic Editor: Ester Boix Received: 18 May 2015 / Accepted: 30 June 2015 / Published: 8 July 2015 Abstract: The eosinophil-derived neurotoxin (EDN/RNase2) and its divergent orthologs, the mouse eosinophil-associated RNases (mEars), are prominent secretory proteins of eosinophilic leukocytes and are all members of the larger family of RNase A-type ribonucleases. While EDN has broad antiviral activity, targeting RNA viruses via mechanisms that may require enzymatic activity, more recent studies have elucidated how these RNases may generate host defense via roles in promoting leukocyte activation, maturation, and chemotaxis. This review provides an update on recent discoveries, and highlights the versatility of this family in promoting innate immunity. Keywords: inflammation; leukocyte; evolution; chemoattractant 1. Introduction The eosinophil-derived neurotoxin (EDN/RNase 2) is one of the four major secretory proteins found in the specific granules of the human eosinophilic leukocyte (Figure 1). EDN, and its more highly charged and cytotoxic paralog, the eosinophil cationic protein (ECP/RNase 3) are released from eosinophil granules when these cells are activated by cytokines and other proinflammatory mediators [1,2]. -
Victor Nizet, M.D
Victor Nizet, M.D. Professor & Vice Chair for Basic Research, Department of Pediatrics Chief, Division of Host-Microbe Systems & Therapeutics University of California, San Diego School of Medicine Professor, Skaggs School of Pharmacy & Pharmaceutical Sciences Biomedical Research Facility II Building, Room 4113 Mail Code 0760, 9500 Gilman Drive, La Jolla, CA 92093-0760 Phone: (858) 534-7408; FAX: (858) 246-1868; email: [email protected] URL: http://nizetlab.ucsd.edu PERSONAL Born Dec 24, 1962 in Augusta, Georgia, USA Married (Christine), Son (Oliver) MAJOR AREAS OF ACADEMIC INTEREST The interest of my laboratory lies in understanding fundamental mechanisms of bacterial pathogenesis and the innate immune system, with a special focus on human streptococcal and staphylococcal infections and emerging antibiotic-resistant pathogens. Using a wide variety of molecular genetic approaches, the laboratory discovers and characterizes bacterial virulence determinants involved in cytotoxicity, adherence, invasion, inflammation, molecular mimicry and resistance to immunologic clearance. In companion studies, we investigate the contribution of host factors such as antimicrobial peptides, cytokines, leukocyte surface receptors, signal transduction pathways, and transcription factors in defense against invasive bacterial infection. Ultimately, we believe the basic discovoeries gained through this platform will inform novel treatment strategies for infectious diseases, including targeted neutralization of microbial virulence phenotypes, pharmacologic augmentation of host immune function, novel monoclonal antibodies and vaccines, and repurposing of FDA-approved drugs to beneficial impact at the host-pathogen interface. My other longstanding academic focus areas include cross-disciplinary research and educational program development, enhancing graduate and postdoctoral training in biological, medical and pharmaceutical sciences, junior faculty development, encouragement of academic-industry collaborations, and public engagement in the sciences. -
Human Cathelicidin LL-37 Is a Chemoattractant for Eosinophils and Neutrophils That Acts Via Formyl-Peptide Receptors
Original Paper Int Arch Allergy Immunol 2006;140:103–112 Received: January 3, 2005 Accepted after revision: December 19, 2005 DOI: 10.1159/000092305 Published online: March 24, 2006 Human Cathelicidin LL-37 Is a Chemoattractant for Eosinophils and Neutrophils That Acts via Formyl-Peptide Receptors a a b G. Sandra Tjabringa Dennis K. Ninaber Jan Wouter Drijfhout a a Klaus F. Rabe Pieter S. Hiemstra a b Departments of Pulmonology, and Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden , The Netherlands Key Words ting using antibodies directed against phosphorylated Eosinophils Neutrophils Chemotaxis Antimicrobial ERK1/2. Results: Our results show that LL-37 chemoat- peptides Innate immunity Lung infl ammation tracts both eosinophils and neutrophils. The FPR antag- onistic peptide tBoc-MLP inhibited LL-37-induced che- motaxis. Whereas the FPR agonist fMLP activated ERK1/2 Abstract in neutrophils, LL-37 did not, indicating that fMLP and Background: Infl ammatory lung diseases such as asth- LL-37 deliver different signals through FPRs. Conclu- ma and chronic obstructive pulmonary disease (COPD) sions: LL-37 displays chemotactic activity for eosinophils are characterized by the presence of eosinophils and and neutrophils, and this activity is mediated via an FPR. neutrophils. However, the mechanisms that mediate the These results suggest that LL-37 may play a role in in- infl ux of these cells are incompletely understood. Neu- fl ammatory lung diseases such as asthma and COPD. trophil products, including neutrophil elastase and anti- Copyright © 2006 S. Karger AG, Basel microbial peptides such as neutrophil defensins and LL- 37, have been demonstrated to display chemotactic activity towards cells from both innate and adaptive im- Introduction munity. -
Instant Notes: Immunology, Second Edition
Immunology Second Edition The INSTANT NOTES series Series Editor: B.D. Hames School of Biochemistry and Molecular Biology, University of Leeds, Leeds, UK Animal Biology 2nd edition Biochemistry 2nd edition Bioinformatics Chemistry for Biologists 2nd edition Developmental Biology Ecology 2nd edition Immunology 2nd edition Genetics 2nd edition Microbiology 2nd edition Molecular Biology 2nd edition Neuroscience Plant Biology Chemistry series Consulting Editor: Howard Stanbury Analytical Chemistry Inorganic Chemistry 2nd edition Medicinal Chemistry Organic Chemistry 2nd edition Physical Chemistry Psychology series Sub-series Editor: Hugh Wagner Dept of Psychology, University of Central Lancashire, Preston, UK Psychology Cognitive Psychology Forthcoming title Physiological Psychology Immunology Second Edition P.M. Lydyard Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, University College London, London, UK A. Whelan Department of Immunology, Trinity College and St James’ Hospital, Dublin, Ireland and M.W. Fanger Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, New Hampshire, USA © Garland Science/BIOS Scientific Publishers Limited, 2004 First published 2000 This edition published in the Taylor & Francis e-Library, 2005. “To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to www.eBookstore.tandf.co.uk.” Second edition published 2004 All rights reserved. No part of this book may be reproduced or -
The Lactoferrin Receptor May Mediate the Reduction of Eosinophils in the Duodenum of Pigs Consuming Milk Containing Recombinant Human Lactoferrin
Biometals DOI 10.1007/s10534-014-9778-8 The lactoferrin receptor may mediate the reduction of eosinophils in the duodenum of pigs consuming milk containing recombinant human lactoferrin Caitlin Cooper • Eric Nonnecke • Bo Lo¨nnerdal • James Murray Received: 11 February 2014 / Accepted: 16 July 2014 Ó Springer Science+Business Media New York 2014 Abstract Lactoferrin is part of the immune system effects of consumption of milk containing recombi- and multiple tissues including the gastrointestinal (GI) nant human lactoferrin (rhLF-milk) on small intestinal tract, liver, and lung contain receptors for lactoferrin. eosinophils and expression of eosinophilic cytokines. Lactoferrin has many functions, including antimicro- In addition, LFR localization was analyzed in duode- bial, immunomodulatory, and iron binding. Addition- num and circulating eosinophils to determine if the ally, lactoferrin inhibits the migration of eosinophils, LFR could play a role in lactoferrin’s ability to inhibit which are constitutively present in the GI tract, and eosinophil migration. In the duodenum there were increase during inflammation. Lactoferrin suppresses significantly fewer eosinophils/unit area in pigs fed eosinophil infiltration into the lungs and eosinophil rhLF-milk compared to pigs fed control milk migration in -vitro. Healthy pigs have a large popu- (p = 0.025); this was not seen in the ileum lation of eosinophils in their small intestine and like (p = 0.669). In the duodenum, no differences were humans, pigs have small intestinal lactoferrin recep- observed in expression of the LFR, or any eosinophil tors (LFR); thus, pigs were chosen to investigate the migratory cytokines, and the amount of LFR protein was not different (p = 0.386). -
Innate Antimicrobial Peptide Protects the Skin from Invasive Bacterial Infection
letters to nature ................................................................. injections of cathelicidin-sensitive GAS in wild-type, heterozygous Innate antimicrobial peptide and homozygous-null mice, CRAMP-de®cient mice were observed to develop much larger areas of infection (Fig. 2a, b). Lesion areas protects the skin from increased more rapidly, reached larger maximal size, and persisted longer in CRAMP-de®cient mice than in normal littermates while invasive bacterial infection heterozygotes tended to have lesions of intermediate size (Fig. 2c). Cultures of equal amounts of tissue from lesions biopsied at day 7 Victor Nizet*, Takaaki Ohtake²³, Xavier Lauth²³, Janet Trowbridge²³, after injection demonstrated persistent infection with b-haemolytic Jennifer Rudisill²³, Robert A. Dorschner²³, Vasumati Pestonjamasp²³, GAS in CRAMP-de®cient mice but not in normal mice (Fig. 2d). No Joseph Piraino§, Kenneth Huttner§ & Richard L. Gallo*²³ difference in GAS lesion size was seen when wild-type parental strains C57BL/6 and 129/SVJ were compared. * Department of Pediatrics; and ² Division of Dermatology, A complementary approach to demonstrating the importance of University of California, San Diego, California 92161, USA cathelicidins in host defence is to examine the effects in vivo of ³ Veterans Affairs San Diego Healthcare System, San Diego, California 92161, altering bacterial sensitivity to CRAMP. If the antimicrobial action USA of cathelicidin is essential to control a GAS skin infection, as § Division of Neonatology, Massachusetts -
Fecal Eosinophil Granule-Derived Proteins Reflect Disease Activity In
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 94, No. 12, 1999 © 1999 by Am. Coll. of Gastroenterology ISSN 0002-9270/99/$20.00 Published by Elsevier Science Inc. PII S0002-9270(99)00699-1 Fecal Eosinophil Granule-Derived Proteins Reflect Disease Activity in Inflammatory Bowel Disease Osamu Saitoh, M.D., Keishi Kojima, M.D., Kazunori Sugi, M.D., Ryoichi Matsuse, Ph.D., Kazuo Uchida, Ph.D., Kazue Tabata, Ph.D., Ken Nakagawa, M.D., Masanobu Kayazawa, M.D., Ichiro Hirata, M.D., and Ken-ichi Katsu, M.D. Second Department of Internal Medicine, Osaka Medical College, Takatsuki, and Kyoto Medical Science Laboratory, Kyoto, Japan OBJECTIVES: The aims of this study were: 1) to examine peroxidase (EPO). These proteins have potent cytotoxic whether the fecal levels of eosinophil granule-derived pro- action and are released from the cells after activation and teins reflect disease activity in inflammatory bowel disease stimulation of the cells (3). Intestinal mucosa of the patients (IBD); and 2) to examine the extracellular release of these with inflammatory bowel disease (IBD) is characterized by proteins from eosinophils and their stability in feces by an in epithelial cell damage and infiltration of various inflamma- vitro study. tory cells. The inflammatory cells include neutrophils, lym- phocytes, plasma cells, macrophages, and eosinophils. Neu- METHODS: We investigated 42 patients with ulcerative co- trophils contain various proteins such as lactoferrin, PMN litis (UC), 37 patients with Crohn’s disease (CD), and 29 (PMN)-elastase, myeloperoxidase, and lysozyme in their control subjects. The stool samples were collected at 4°C granules. We previously reported that the fecal levels of over 48 h and were homogenized. -
Comparative Properties of the Charcot-Leyden Crystal Protein and the Major Basic Protein from Human Eosinophils
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. G J Gleich, … , K G Mann, J E Maldonado J Clin Invest. 1976;57(3):633-640. https://doi.org/10.1172/JCI108319. Research Article Guinea pig eosinophil granules contain a protein, the major basic protein (MBP), which accounts for more than half of the total granule protein, has a high content of arginine, and displays a remarkable tendency to form disulfide-linked aggregates. In this study we have purified a similar protein from human eosinophil granules and have compared the human MBP to the protein comprising the Charcot-Leyden crystal (CLC). Eosinophils from patients with various diseases were purified and disrupted, and the granule fraction was obtained. Examination of the granule fraction by transmission electron microscopy showed numerous typical eosinophil granules. Analyses of granule lysates by gel filtration and by polyacrylamide gel electrophoresis revealed the presence of peroxidase and MBP with properties similar to that previously found in guinea pig eosinophil granules. The human MBP had a molecular weight of 9,200, contained less than 1% carbohydrate, was rich in arginine, and readily formed disulfide-bonded aggregates. CLC were prepared from eosinophil-rich cell suspensions by homogenization in hypotonic saline. The supernates following centrifugation of cell debris spontaneously formed CLC. Analysis of CLC revealed the presence of a protein with a molecular weight of 13,000 containing 1.2% carbohydrate. The protein displayed a remarkable tendency to aggregate even in the presence of 0.2 M acetic acid. Human MBP and CLC protein differed in their molecular weights, carbohydrate compositions, and amino […] Find the latest version: https://jci.me/108319/pdf Comparative Properties of the Charcot-Leyden Crystal Protein and the Major Basic Protein from Human Eosinophils GERALD J. -
Endogenous Production of Antimicrobial Peptides in Innate Immunity and Human Disease Richard L
Endogenous Production of Antimicrobial Peptides in Innate Immunity and Human Disease Richard L. Gallo, MD, PhD, and Victor Nizet, MD Address The definition of an AMP has been loosely applied to Departments of Medicine and Pediatrics, Division of Dermatology, Uni- any peptide with the capacity to inhibit the growth of versity of California San Diego, and VA San Diego Healthcare System, microbes. AMPs might exhibit potent killing or inhibi- San Diego, CA, USA. E-mail: [email protected] tion of a broad range of microorganisms, including gram- positive and -negative bacteria as well as fungi and certain Current Allergy and Asthma Reports 2003, 3:402–409 Current Science Inc. ISSN 1529-7322 viruses. More than 800 such AMPs have been described, Copyright © 2003 by Current Science Inc. and an updated list can be found at the website: http:// www.bbcm.units.it/~tossi/pag1.htm. Some of these AMPs Antimicrobial peptides are diverse and evolutionarily ancient have now been demonstrated to protect diverse organ- molecules produced by all living organisms. Peptides belong- isms, including plants, insects, and mammals, against ing to the cathelicidin and defensin gene families exhibit an infection. AMP sequence analysis has shown that the pep- immune strategy as they defend against infection by inhibiting tide immune system is evolutionarily ancient, and the microbial survival, and modify hosts through triggering tis- conservation of AMP gene families throughout the ani- sue-specific defense and repair events. A variety of processes mal kingdom further supports their biologic significance. have evolved in microbes to evade the action of antimicrobial Antimicrobial peptides function within the conceptual peptides, including the ability to degrade or inactivate antimi- framework of the innate immune system. -
3970.Full.Pdf
Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and This information is current as Independent Signaling Pathways of September 27, 2021. Philipp Henneke, Osamu Takeuchi, Richard Malley, Egil Lien, Robin R. Ingalls, Mason W. Freeman, Tanya Mayadas, Victor Nizet, Shizuo Akira, Dennis L. Kasper and Douglas T. Golenbock Downloaded from J Immunol 2002; 169:3970-3977; ; doi: 10.4049/jimmunol.169.7.3970 http://www.jimmunol.org/content/169/7/3970 http://www.jimmunol.org/ References This article cites 61 articles, 36 of which you can access for free at: http://www.jimmunol.org/content/169/7/3970.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Cellular Activation, Phagocytosis, and Bactericidal Activity Against Group B Streptococcus Involve Parallel Myeloid Differentiation Factor 88-Dependent and Independent Signaling Pathways1 Philipp Henneke,*† Osamu Takeuchi,‡ Richard Malley,§ Egil Lien,* Robin R. -
Physiochemical and Biological Properties of the Major Basic Protein from Guinea Pig Eosinophil Granules* by Gerald J
PHYSIOCHEMICAL AND BIOLOGICAL PROPERTIES OF THE MAJOR BASIC PROTEIN FROM GUINEA PIG EOSINOPHIL GRANULES* BY GERALD J. GLEICH, DAVID A. LOEGERING, FRIEDRICH KUEPPERS, SATYA P. BAJAJ, AND KENNETH G. MANN (From the Departments of Medicine, Microbiology, and Immunology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55901) (Received for publication 18 March 1974) The functions of eosinophils not shared by neutrophils remain obscure in spite of numerous investigations and an enormous amount of literature dealing with observations of laboratory animals and patients (1-3). It seems likely that the specific functions of the eosinophil are related to the distinctive granules associated with this cell. In the past, a variety of investigators have purified eosinophil granules and investigated their properties. Vercauteren isolated eosinophil granules from horse eosinophils and analyzed the granule material (4, 5). His studies suggested the presence of arginine-rich proteins in the granules which functioned as an antihistamine. Archer and Hirsch purified rat and horse eosinophils and isolated granules from these cells. Their studies showed that eosinophil granules differed from neutrophil granules in that eosinophil granules contained a high content of peroxidase and did not contain lysozyme and phagocytin (6). More recently Gessner and his associates ana- lyzed the proteins in guinea pig eosinophil granules and identified four major and several minor proteins (7). We have described methods for the purification of eosinophils and neutro- phils from the peritoneal cavity of the guinea pig (8) and have identified a major basic protein (MBP) 1 present in eosinophil granules (9). This protein does not possess peroxidase activity and accounts for approximately 55 % of the total granule protein. -
Erratum Cells, Suggesting That the Granule Proteins Had Been Secreted Externally (Fig
=lM~-----------------------------------LETTERSTONATURE------------------~N~AT~U~R~E~V~O~L~.~3W~IO~M~A~Y~I~984 numbers of activated cells were found in the skin biopsies from Table I Specificities of monoclonal antibodies EG I and EG2 for 12 out of 14 patients studied, and in some patients this was human eosinophil granule proteins associated with areas of extracellular deposits of eosinophil Monoclonal antibodies secretion products (Fig. 3). Disease severity appeared to corre Purified granule protein EGI EG2 late with the presence of these activated cells. The cross-reactivity of EG2 on ECP and on an epitope on Eosinophil granule proteins Optical density at 450 nm EP-X suggested that there were structural similarities between Eosinophil cationic protein, ECP 0.89* 1.02* these two proteins, at least on secretion. As these two cationic posinophil protein X, EP-X 0.16 0.95* proteins are of similar molecular size, with closely related physi 6 Major basic protein, MBP 0.09 0.06 cochemical and biological properties , it is possible that they Peroxidase, EPO 0.13 0.15 are structurally related. Neutrophil granule proteins The observation of numerous activated eosinophils and their Chymotrypsin-like cationic protein 0.08 0.06 Elastase 0.08 0.12 secretion products in the skin supports the view that eosinophils Lactoferrin 0.16 0.13 may contribute to tissue injury. It is now possible to extend Myeloperoxidase 0.14 0.09 these studies to other diseases in which eosinophil activation and degranulation in tissues have been thought to occur. The ECP